• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

赖氨酸去甲基化酶KDM4A与翻译机制相关联并调节蛋白质合成。

Lysine demethylase KDM4A associates with translation machinery and regulates protein synthesis.

作者信息

Van Rechem Capucine, Black Joshua C, Boukhali Myriam, Aryee Martin J, Gräslund Susanne, Haas Wilhelm, Benes Cyril H, Whetstine Johnathan R

机构信息

Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Charlestown, Massachusetts.

Massachusetts General Hospital Department of Pathology and Department of Medicine, Harvard Medical School, Charlestown, Massachusetts.

出版信息

Cancer Discov. 2015 Mar;5(3):255-63. doi: 10.1158/2159-8290.CD-14-1326. Epub 2015 Jan 6.

DOI:10.1158/2159-8290.CD-14-1326
PMID:25564516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4355328/
Abstract

UNLABELLED

Chromatin-modifying enzymes are predominantly nuclear; however, these factors are also localized to the cytoplasm, and very little is known about their role in this compartment. In this report, we reveal a non-chromatin-linked role for the lysine-specific demethylase KDM4A. We demonstrate that KDM4A interacts with the translation initiation complex and affects the distribution of translation initiation factors within polysome fractions. Furthermore, KDM4A depletion reduced protein synthesis and enhanced the protein synthesis suppression observed with mTOR inhibitors, which paralleled an increased sensitivity to these drugs. Finally, we demonstrate that JIB-04, a JmjC demethylase inhibitor, suppresses translation initiation and enhances mTOR inhibitor sensitivity. These data highlight an unexpected cytoplasmic role for KDM4A in regulating protein synthesis and suggest novel potential therapeutic applications for this class of enzyme.

SIGNIFICANCE

This report documents an unexpected cytoplasmic role for the lysine demethylase KDM4A. We demonstrate that KDM4A interacts with the translation initiation machinery, regulates protein synthesis and, upon coinhibition with mTOR inhibitors, enhances the translation suppression and cell sensitivity to these therapeutics.

摘要

未标记

染色质修饰酶主要定位于细胞核;然而,这些因子也存在于细胞质中,而关于它们在这个区室中的作用却知之甚少。在本报告中,我们揭示了赖氨酸特异性去甲基化酶KDM4A的一种非染色质相关作用。我们证明KDM4A与翻译起始复合物相互作用,并影响多核糖体组分中翻译起始因子的分布。此外,KDM4A的缺失降低了蛋白质合成,并增强了用mTOR抑制剂观察到的蛋白质合成抑制,这与对这些药物的敏感性增加相平行。最后,我们证明JmjC去甲基化酶抑制剂JIB-04抑制翻译起始并增强mTOR抑制剂敏感性。这些数据突出了KDM4A在调节蛋白质合成中意想不到的细胞质作用,并提示了这类酶新的潜在治疗应用。

意义

本报告记录了赖氨酸去甲基化酶KDM4A意想不到的细胞质作用。我们证明KDM4A与翻译起始机制相互作用,调节蛋白质合成,并且在与mTOR抑制剂共同抑制时,增强翻译抑制和细胞对这些治疗药物的敏感性。

相似文献

1
Lysine demethylase KDM4A associates with translation machinery and regulates protein synthesis.赖氨酸去甲基化酶KDM4A与翻译机制相关联并调节蛋白质合成。
Cancer Discov. 2015 Mar;5(3):255-63. doi: 10.1158/2159-8290.CD-14-1326. Epub 2015 Jan 6.
2
A coding single-nucleotide polymorphism in lysine demethylase KDM4A associates with increased sensitivity to mTOR inhibitors.赖氨酸去甲基化酶KDM4A中的一个编码单核苷酸多态性与对mTOR抑制剂的敏感性增加相关。
Cancer Discov. 2015 Mar;5(3):245-54. doi: 10.1158/2159-8290.CD-14-1159. Epub 2015 Jan 6.
3
From histones to ribosomes: a chromatin regulator tangoes with translation.从组蛋白到核糖体:一种染色质调节因子与翻译共舞。
Cancer Discov. 2015 Mar;5(3):228-30. doi: 10.1158/2159-8290.CD-15-0073.
4
The small molecule JIB-04 disrupts O binding in the Fe-dependent histone demethylase KDM4A/JMJD2A.小分子JIB-04可破坏铁依赖性组蛋白去甲基化酶KDM4A/JMJD2A中的氧结合。
Chem Commun (Camb). 2017 Feb 9;53(13):2174-2177. doi: 10.1039/c6cc09882g.
5
Histone demethylase KDM4A plays an oncogenic role in nasopharyngeal carcinoma by promoting cell migration and invasion.组蛋白去甲基化酶 KDM4A 通过促进细胞迁移和侵袭在鼻咽癌中发挥致癌作用。
Exp Mol Med. 2021 Aug;53(8):1207-1217. doi: 10.1038/s12276-021-00657-0. Epub 2021 Aug 12.
6
SCF(FBXO22) regulates histone H3 lysine 9 and 36 methylation levels by targeting histone demethylase KDM4A for ubiquitin-mediated proteasomal degradation.SCF(FBXO22)通过靶向组蛋白去甲基化酶 KDM4A 进行泛素介导的蛋白酶体降解来调节组蛋白 H3 赖氨酸 9 和 36 的甲基化水平。
Mol Cell Biol. 2011 Sep;31(18):3687-99. doi: 10.1128/MCB.05746-11. Epub 2011 Jul 18.
7
The histone demethylase JMJD2A/KDM4A links ribosomal RNA transcription to nutrients and growth factors availability.组蛋白去甲基化酶JMJD2A/KDM4A将核糖体RNA转录与营养物质及生长因子的可利用性联系起来。
Nat Commun. 2016 Jan 5;7:10174. doi: 10.1038/ncomms10174.
8
Disruption of the Life Cycle through Transcriptional Reprogramming by Inhibitors of Jumonji Demethylases.通过组蛋白去甲基化酶抑制剂的转录重编程破坏生命周期。
ACS Infect Dis. 2020 May 8;6(5):1058-1075. doi: 10.1021/acsinfecdis.9b00455. Epub 2020 Apr 24.
9
Inhibition of Jumonji Histone Demethylases Selectively Suppresses HER2 Breast Leptomeningeal Carcinomatosis Growth via Inhibition of GMCSF Expression.抑制 Jumonji 组蛋白去甲基酶通过抑制 GMCSF 表达选择性抑制 HER2 乳腺癌软脑膜转移生长。
Cancer Res. 2021 Jun 15;81(12):3200-3214. doi: 10.1158/0008-5472.CAN-20-3317. Epub 2021 May 3.
10
The role of the histone demethylase KDM4A in cancer.组蛋白去甲基化酶KDM4A在癌症中的作用。
Cancer Genet. 2015 May;208(5):215-24. doi: 10.1016/j.cancergen.2014.11.001. Epub 2014 Nov 20.

引用本文的文献

1
Epigenetic, ribosomal, and immune dysregulation in paediatric acute-onset neuropsychiatric syndrome.儿童急性起病神经精神综合征中的表观遗传、核糖体及免疫失调
Mol Psychiatry. 2025 Aug 30. doi: 10.1038/s41380-025-03127-5.
2
Connecting the dots: Epigenetic regulation of extrachromosomal and inherited DNA amplifications.连点成线:染色体外及遗传性DNA扩增的表观遗传调控
J Biol Chem. 2025 Mar 26;301(6):108454. doi: 10.1016/j.jbc.2025.108454.
3
Analogue-Sensitive Inhibition of Histone Demethylases Uncovers Member-Specific Function in Ribosomal Protein Synthesis.

本文引用的文献

1
Examining the impact of gene variants on histone lysine methylation.研究基因变异对组蛋白赖氨酸甲基化的影响。
Biochim Biophys Acta. 2014 Dec;1839(12):1463-76. doi: 10.1016/j.bbagrm.2014.05.014. Epub 2014 May 23.
2
SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer.SMYD3 将赖氨酸甲基化与 Ras 驱动的癌症联系起来。
Nature. 2014 Jun 12;510(7504):283-7. doi: 10.1038/nature13320. Epub 2014 May 21.
3
Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes.
组蛋白去甲基酶的类似物敏感抑制揭示核糖体蛋白合成中的成员特异性功能。
J Am Chem Soc. 2025 Jan 29;147(4):3341-3352. doi: 10.1021/jacs.4c13870. Epub 2025 Jan 14.
4
Absence of SMARCB1 in rhabdoid tumor cells increases sensitivity to translation inhibition and alters translation efficiency of specific mRNAs.横纹肌样瘤细胞中SMARCB1的缺失增加了对翻译抑制的敏感性,并改变了特定mRNA的翻译效率。
J Biol Chem. 2024 Dec;300(12):107988. doi: 10.1016/j.jbc.2024.107988. Epub 2024 Nov 13.
5
Versatile JMJD proteins: juggling histones and much more.多功能 JMJD 蛋白:玩转组蛋白及更多。
Trends Biochem Sci. 2024 Sep;49(9):804-818. doi: 10.1016/j.tibs.2024.06.009. Epub 2024 Jun 26.
6
Epigenetic modulators provide a path to understanding disease and therapeutic opportunity.表观遗传调节剂为理解疾病和提供治疗机会开辟了道路。
Genes Dev. 2024 Jul 19;38(11-12):473-503. doi: 10.1101/gad.351444.123.
7
Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma.组蛋白赖氨酸去甲基酶 4 家族蛋白维持 MYCN 扩增神经母细胞瘤的转录程序和肾上腺素能细胞状态。
Cell Rep Med. 2024 Mar 19;5(3):101468. doi: 10.1016/j.xcrm.2024.101468.
8
Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis.肾胚层来源致癌细胞对小分子抑制剂 QC6352 敏感,表现为 KDM4 水平耗竭和核糖体生物发生破坏。
Mol Cancer Ther. 2024 Apr 2;23(4):478-491. doi: 10.1158/1535-7163.MCT-23-0312.
9
SET7/9-mediated methylation affects oncogenic functions of histone demethylase JMJD2A.SET7/9 介导的甲基化影响组蛋白去甲基酶 JMJD2A 的致癌功能。
JCI Insight. 2023 Oct 23;8(20):e164990. doi: 10.1172/jci.insight.164990.
10
KDM4 Demethylases: Structure, Function, and Inhibitors.KDM4去甲基化酶:结构、功能及抑制剂
Adv Exp Med Biol. 2023;1433:87-111. doi: 10.1007/978-3-031-38176-8_5.
使用 mTOR 抑制剂治疗乳腺癌:评估影响患者结局的因素。
Breast Cancer (Dove Med Press). 2014 Apr 17;6:43-57. doi: 10.2147/BCTT.S38679. eCollection 2014.
4
Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer.针对雌激素受体阳性乳腺癌中的 PI3K/AKT/mTOR 通路。
Cancer Treat Rev. 2014 Aug;40(7):862-71. doi: 10.1016/j.ctrv.2014.03.004. Epub 2014 Mar 26.
5
KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors.KDM4A 赖氨酸去甲基酶诱导肿瘤中扩增区域的特异性拷贝数增加和重复制。
Cell. 2013 Aug 1;154(3):541-55. doi: 10.1016/j.cell.2013.06.051. Epub 2013 Jul 18.
6
A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth.一种小分子调节 Jumonji 组蛋白去甲基化酶活性并选择性抑制癌症生长。
Nat Commun. 2013;4:2035. doi: 10.1038/ncomms3035.
7
KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells.KDM4/JMJD2 组蛋白去甲基化酶:癌细胞中的表观遗传调节剂。
Cancer Res. 2013 May 15;73(10):2936-42. doi: 10.1158/0008-5472.CAN-12-4300. Epub 2013 May 3.
8
KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs.KDM2B 通过 Polycomb 依赖性和非依赖性转录程序促进胰腺癌。
J Clin Invest. 2013 Feb;123(2):727-39. doi: 10.1172/JCI64535. Epub 2013 Jan 16.
9
Histone lysine methylation dynamics: establishment, regulation, and biological impact.组蛋白赖氨酸甲基化动态:建立、调控和生物学影响。
Mol Cell. 2012 Nov 30;48(4):491-507. doi: 10.1016/j.molcel.2012.11.006.
10
Combined PI3K/mTOR and MEK inhibition provides broad antitumor activity in faithful murine cancer models.联合 PI3K/mTOR 和 MEK 抑制在忠实的鼠类癌症模型中提供广泛的抗肿瘤活性。
Clin Cancer Res. 2012 Oct 1;18(19):5290-303. doi: 10.1158/1078-0432.CCR-12-0563. Epub 2012 Aug 7.